Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental Health Day yesterday, we want to share with you some of the latest technologies that address these conditions.
Yesterday, October 10th, was World Mental Health Day: it is dedicated to raising awareness of neurological and mental disorders that affect 25% of the world’s population as one of the main causes of lifelong disability. Biotech is committed to finding new, effective technology to treat all these conditions.
Although unfortunately we can’t cover it all, we’ve collected a few of the most promising strategies that have emerged this year:
Epilepsy is the most common brain disorder, affecting 50 million people worldwide. Although most patients can live a normal life using antiepileptic drugs, 30% do not respond to conventional treatments.
However, GW Pharmaceuticals has come to the rescue of children with drug-resistant epilepsy. The company just reported successful results from a Phase III trial for the cannabinoid drug Epidiolex.